Chronic  ||| S:0 E:8 ||| JJ
migraine ||| S:8 E:16 ||| NN
:  ||| S:16 E:18 ||| :
clinical  ||| S:18 E:27 ||| JJ
manifestations  ||| S:27 E:42 ||| NNS
and  ||| S:42 E:46 ||| CC
differential  ||| S:46 E:59 ||| FW
diagnosis  ||| S:59 E:69 ||| FW
Chronic  ||| S:69 E:77 ||| FW
migraine  ||| S:77 E:86 ||| FW
is  ||| S:86 E:89 ||| VBZ
a  ||| S:89 E:91 ||| DT
condition  ||| S:91 E:101 ||| NN
that  ||| S:101 E:106 ||| WDT
has  ||| S:106 E:110 ||| VBZ
been  ||| S:110 E:115 ||| VBN
present  ||| S:115 E:123 ||| JJ
since  ||| S:123 E:129 ||| IN
the  ||| S:129 E:133 ||| DT
dawn  ||| S:133 E:138 ||| NN
of  ||| S:138 E:141 ||| IN
medicine ||| S:141 E:149 ||| NN
,  ||| S:149 E:151 ||| ,
although  ||| S:151 E:160 ||| IN
only  ||| S:160 E:165 ||| RB
recently  ||| S:165 E:174 ||| RB
has  ||| S:174 E:178 ||| VBZ
progress  ||| S:178 E:187 ||| NN
been  ||| S:187 E:192 ||| VBN
made  ||| S:192 E:197 ||| VBN
in  ||| S:197 E:200 ||| IN
characterising  ||| S:200 E:215 ||| VBG
it  ||| S:215 E:218 ||| PRP
nosologically ||| S:218 E:231 ||| VBD
.  ||| S:231 E:233 ||| .
It  ||| S:233 E:236 ||| PRP
is  ||| S:236 E:239 ||| VBZ
the  ||| S:239 E:243 ||| DT
result  ||| S:243 E:250 ||| NN
of  ||| S:250 E:253 ||| IN
the  ||| S:253 E:257 ||| DT
evolution  ||| S:257 E:267 ||| NN
of  ||| S:267 E:270 ||| IN
episodic  ||| S:270 E:279 ||| JJ
migraine  ||| S:279 E:288 ||| NN
which ||| S:288 E:293 ||| WDT
,  ||| S:293 E:295 ||| ,
at  ||| S:295 E:298 ||| IN
one  ||| S:298 E:302 ||| CD
particular  ||| S:302 E:313 ||| JJ
moment  ||| S:313 E:320 ||| NN
and  ||| S:320 E:324 ||| CC
in  ||| S:324 E:327 ||| IN
relation  ||| S:327 E:336 ||| NN
to  ||| S:336 E:339 ||| TO
certain  ||| S:339 E:347 ||| JJ
risk  ||| S:347 E:352 ||| NN
factors ||| S:352 E:359 ||| NNS
,  ||| S:359 E:361 ||| ,
changes  ||| S:361 E:369 ||| VBZ
its  ||| S:369 E:373 ||| PRP$
characteristics ||| S:373 E:388 ||| NNS
.  ||| S:388 E:390 ||| .
The  ||| S:390 E:394 ||| DT
diagnostic  ||| S:394 E:405 ||| JJ
criteria  ||| S:405 E:414 ||| NNS
of  ||| S:414 E:417 ||| IN
chronic  ||| S:417 E:425 ||| JJ
migraine ||| S:425 E:433 ||| NN
,  ||| S:433 E:435 ||| ,
which  ||| S:435 E:441 ||| WDT
were  ||| S:441 E:446 ||| VBD
initially  ||| S:446 E:456 ||| RB
very  ||| S:456 E:461 ||| RB
restrictive  ||| S:461 E:473 ||| JJ
and  ||| S:473 E:477 ||| CC
based  ||| S:477 E:483 ||| VBN
on  ||| S:483 E:486 ||| IN
the  ||| S:486 E:490 ||| DT
specific  ||| S:490 E:499 ||| JJ
type  ||| S:499 E:504 ||| NN
of  ||| S:504 E:507 ||| IN
patient  ||| S:507 E:515 ||| NN
from  ||| S:515 E:520 ||| IN
the  ||| S:520 E:524 ||| DT
most  ||| S:524 E:529 ||| RBS
important  ||| S:529 E:539 ||| JJ
headache  ||| S:539 E:548 ||| NN
units ||| S:548 E:553 ||| NNS
,  ||| S:553 E:555 ||| ,
are  ||| S:555 E:559 ||| VBP
gradually  ||| S:559 E:569 ||| RB
being  ||| S:569 E:575 ||| VBG
adjusted  ||| S:575 E:584 ||| VBN
to  ||| S:584 E:587 ||| TO
match  ||| S:587 E:593 ||| VB
the  ||| S:593 E:597 ||| DT
real  ||| S:597 E:602 ||| JJ
situation  ||| S:602 E:612 ||| NN
experienced  ||| S:612 E:624 ||| VBN
in  ||| S:624 E:627 ||| IN
most  ||| S:627 E:632 ||| RBS
neurology  ||| S:632 E:642 ||| JJ
departments ||| S:642 E:653 ||| NNS
.  ||| S:653 E:655 ||| .
The  ||| S:655 E:659 ||| DT
consideration  ||| S:659 E:673 ||| NN
of  ||| S:673 E:676 ||| IN
medication  ||| S:676 E:687 ||| NN
abuse  ||| S:687 E:693 ||| NN
criteria  ||| S:693 E:702 ||| NNS
has  ||| S:702 E:706 ||| VBZ
also  ||| S:706 E:711 ||| RB
evolved  ||| S:711 E:719 ||| VBN
and  ||| S:719 E:723 ||| CC
this  ||| S:723 E:728 ||| DT
has  ||| S:728 E:732 ||| VBZ
made  ||| S:732 E:737 ||| VBN
it  ||| S:737 E:740 ||| PRP
possible  ||| S:740 E:749 ||| JJ
to  ||| S:749 E:752 ||| TO
perform  ||| S:752 E:760 ||| VB
a  ||| S:760 E:762 ||| DT
prospective  ||| S:762 E:774 ||| JJ
diagnosis  ||| S:774 E:784 ||| NN
of  ||| S:784 E:787 ||| IN
these  ||| S:787 E:793 ||| DT
cases ||| S:793 E:798 ||| NNS
,  ||| S:798 E:800 ||| ,
instead  ||| S:800 E:808 ||| RB
of  ||| S:808 E:811 ||| IN
requiring  ||| S:811 E:821 ||| VBG
withdrawal  ||| S:821 E:832 ||| NN
from  ||| S:832 E:837 ||| IN
the  ||| S:837 E:841 ||| DT
abuse ||| S:841 E:846 ||| NN
,  ||| S:846 E:848 ||| ,
which  ||| S:848 E:854 ||| WDT
is  ||| S:854 E:857 ||| VBZ
not  ||| S:857 E:861 ||| RB
also  ||| S:861 E:866 ||| RB
feasible  ||| S:866 E:875 ||| JJ
in  ||| S:875 E:878 ||| IN
practice ||| S:878 E:886 ||| NN
.  ||| S:886 E:888 ||| .
The  ||| S:888 E:892 ||| DT
influence  ||| S:892 E:902 ||| NN
of  ||| S:902 E:905 ||| IN
medication  ||| S:905 E:916 ||| NN
abuse  ||| S:916 E:922 ||| NN
in  ||| S:922 E:925 ||| IN
the  ||| S:925 E:929 ||| DT
development  ||| S:929 E:941 ||| NN
of  ||| S:941 E:944 ||| IN
chronic  ||| S:944 E:952 ||| JJ
migraine  ||| S:952 E:961 ||| NN
remains  ||| S:961 E:969 ||| VBZ
a  ||| S:969 E:971 ||| DT
controversial  ||| S:971 E:985 ||| JJ
issue ||| S:985 E:990 ||| NN
.  ||| S:990 E:992 ||| .
In  ||| S:992 E:995 ||| IN
our  ||| S:995 E:999 ||| PRP$
opinion ||| S:999 E:1006 ||| NN
,  ||| S:1006 E:1008 ||| ,
abuse  ||| S:1008 E:1014 ||| NN
is  ||| S:1014 E:1017 ||| VBZ
an  ||| S:1017 E:1020 ||| DT
important  ||| S:1020 E:1030 ||| JJ
risk  ||| S:1030 E:1035 ||| NN
factor  ||| S:1035 E:1042 ||| NN
for  ||| S:1042 E:1046 ||| IN
the  ||| S:1046 E:1050 ||| DT
chronification  ||| S:1050 E:1065 ||| NN
of  ||| S:1065 E:1068 ||| IN
migraine ||| S:1068 E:1076 ||| NN
,  ||| S:1076 E:1078 ||| ,
but  ||| S:1078 E:1082 ||| CC
it  ||| S:1082 E:1085 ||| PRP
is  ||| S:1085 E:1088 ||| VBZ
not  ||| S:1088 E:1092 ||| RB
a  ||| S:1092 E:1094 ||| DT
necessary  ||| S:1094 E:1104 ||| JJ
or  ||| S:1104 E:1107 ||| CC
a  ||| S:1107 E:1109 ||| DT
sufficient  ||| S:1109 E:1120 ||| JJ
condition  ||| S:1120 E:1130 ||| NN
for  ||| S:1130 E:1134 ||| IN
it  ||| S:1134 E:1137 ||| PRP
to  ||| S:1137 E:1140 ||| TO
become  ||| S:1140 E:1147 ||| VB
chronic ||| S:1147 E:1154 ||| NN
.  ||| S:1154 E:1156 ||| .
Like  ||| S:1156 E:1161 ||| IN
other  ||| S:1161 E:1167 ||| JJ
authors ||| S:1167 E:1174 ||| NNS
,  ||| S:1174 E:1176 ||| ,
we  ||| S:1176 E:1179 ||| PRP
recommend  ||| S:1179 E:1189 ||| VBP
the  ||| S:1189 E:1193 ||| DT
use  ||| S:1193 E:1197 ||| NN
of  ||| S:1197 E:1200 ||| IN
the  ||| S:1200 E:1204 ||| DT
term  ||| S:1204 E:1209 ||| NN
' ||| S:1209 E:1210 ||| POS
chronic  ||| S:1210 E:1218 ||| JJ
migraine ||| S:1218 E:1226 ||| NN
'  ||| S:1226 E:1228 ||| POS
indistinctly  ||| S:1228 E:1241 ||| NN
for  ||| S:1241 E:1245 ||| IN
patients  ||| S:1245 E:1254 ||| NNS
with  ||| S:1254 E:1259 ||| IN
or  ||| S:1259 E:1262 ||| CC
without  ||| S:1262 E:1270 ||| IN
abuse ||| S:1270 E:1275 ||| NN
.  ||| S:1275 E:1277 ||| .
The  ||| S:1277 E:1281 ||| DT
diagnosis  ||| S:1281 E:1291 ||| NN
of  ||| S:1291 E:1294 ||| IN
chronic  ||| S:1294 E:1302 ||| JJ
migraine  ||| S:1302 E:1311 ||| NN
is  ||| S:1311 E:1314 ||| VBZ
not  ||| S:1314 E:1318 ||| RB
always  ||| S:1318 E:1325 ||| RB
a  ||| S:1325 E:1327 ||| DT
simple  ||| S:1327 E:1334 ||| JJ
matter ||| S:1334 E:1340 ||| NN
;  ||| S:1340 E:1342 ||| :
the  ||| S:1342 E:1346 ||| DT
anamnesis  ||| S:1346 E:1356 ||| NN
is  ||| S:1356 E:1359 ||| VBZ
our  ||| S:1359 E:1363 ||| PRP$
best  ||| S:1363 E:1368 ||| JJS
weapon ||| S:1368 E:1374 ||| NN
,  ||| S:1374 E:1376 ||| ,
although  ||| S:1376 E:1385 ||| IN
in  ||| S:1385 E:1388 ||| IN
our  ||| S:1388 E:1392 ||| PRP$
patients  ||| S:1392 E:1401 ||| NNS
with  ||| S:1401 E:1406 ||| IN
headache  ||| S:1406 E:1415 ||| VBG
we  ||| S:1415 E:1418 ||| PRP
must  ||| S:1418 E:1423 ||| MD
get  ||| S:1423 E:1427 ||| VB
used  ||| S:1427 E:1432 ||| VBN
to  ||| S:1432 E:1435 ||| TO
taking  ||| S:1435 E:1442 ||| VBG
into  ||| S:1442 E:1447 ||| IN
account  ||| S:1447 E:1455 ||| NN
not  ||| S:1455 E:1459 ||| RB
only  ||| S:1459 E:1464 ||| RB
the  ||| S:1464 E:1468 ||| DT
most  ||| S:1468 E:1473 ||| RBS
striking  ||| S:1473 E:1482 ||| JJ
bouts  ||| S:1482 E:1488 ||| NNS
of  ||| S:1488 E:1491 ||| IN
pain  ||| S:1491 E:1496 ||| NN
but  ||| S:1496 E:1500 ||| CC
also  ||| S:1500 E:1505 ||| RB
the  ||| S:1505 E:1509 ||| DT
intercritical  ||| S:1509 E:1523 ||| JJ
periods ||| S:1523 E:1530 ||| NNS
.  ||| S:1530 E:1532 ||| .
The  ||| S:1532 E:1536 ||| DT
differential  ||| S:1536 E:1549 ||| JJ
diagnosis  ||| S:1549 E:1559 ||| NN
has  ||| S:1559 E:1563 ||| VBZ
to  ||| S:1563 E:1566 ||| TO
be  ||| S:1566 E:1569 ||| VB
considered  ||| S:1569 E:1580 ||| VBN
in  ||| S:1580 E:1583 ||| IN
cases  ||| S:1583 E:1589 ||| NNS
of  ||| S:1589 E:1592 ||| IN
chronic  ||| S:1592 E:1600 ||| JJ
headaches  ||| S:1600 E:1610 ||| NNS
with  ||| S:1610 E:1615 ||| IN
prolonged  ||| S:1615 E:1625 ||| JJ
episodes  ||| S:1625 E:1634 ||| NNS
of  ||| S:1634 E:1637 ||| IN
pain ||| S:1637 E:1641 ||| NN
.  ||| S:1641 E:1643 ||| .
We  ||| S:1643 E:1646 ||| PRP
draw  ||| S:1646 E:1651 ||| VBP
special  ||| S:1651 E:1659 ||| JJ
attention  ||| S:1659 E:1669 ||| NN
to  ||| S:1669 E:1672 ||| TO
its  ||| S:1672 E:1676 ||| PRP$
differentiation  ||| S:1676 E:1692 ||| NN
from  ||| S:1692 E:1697 ||| IN
tension-type  ||| S:1697 E:1710 ||| JJ
headache  ||| S:1710 E:1719 ||| NN
and  ||| S:1719 E:1723 ||| CC
we  ||| S:1723 E:1726 ||| PRP
recommend  ||| S:1726 E:1736 ||| VBP
avoiding  ||| S:1736 E:1745 ||| VBG
whenever  ||| S:1745 E:1754 ||| WRB
possible  ||| S:1754 E:1763 ||| JJ
the  ||| S:1763 E:1767 ||| DT
use  ||| S:1767 E:1771 ||| NN
of  ||| S:1771 E:1774 ||| IN
the  ||| S:1774 E:1778 ||| DT
term  ||| S:1778 E:1783 ||| NN
' ||| S:1783 E:1784 ||| POS
mixed  ||| S:1784 E:1790 ||| JJ
headache ||| S:1790 E:1798 ||| NN
' ||| S:1798 E:1799 ||| POS
.  ||| S:1799 E:1801 ||| .
